BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Xenomics

Xenomics, Inc. is the developer of next-generation molecular diagnostics products that address important health problems worldwide. Our mission is to apply our proprietary transrenal DNA test platform to develop highly sensitive, truly non-invasive molecular diagnostics that replace outdated blood, sputum, and tissue testing technologies many of which are not sufficiently sensitive and specific, and are often hazardous, and difficult to automate. The patented technology uses simple urine specimens and can be applied to a broad range of products addressing multi-billion dollar markets including infectious disease detection and monitoring, cancer detection and monitoring, prenatal genetic testing, monitoring organ/cell transplants, human forensics, and biodefense. Xenomics has made continuing progress in its clinical studies in infectious disease testing, particularly in the field of TB detection and therapeutic monitoring, HIV proviral DNA detection, and detection of early cancer genetic markers.


Contact Details:
420 Lexington Avenue Suite 170
New York
New York
10170
United States of America
Tel:(212) 297-0808
Fax:(212) 297-1888
Email:info@xenomics.com
WWW:

www.xenomics.com/




Loading...

Recent Publications by Xenomics:

Transrenal DNA testing: progress and perspectives.
Transrenal DNA (Tr-DNA) is a recently discovered class of extracellular...
30th June, 2006
Xenomics Inc., Monmouth Expert Rev Mol Diagn. 2006 Mar;6(2):153-63.
DOI Direct Link
Apoptosis in the myocardium: much is still expected.
Apoptosis continues to be a controversial concept and subject of debate...
2nd May, 2006
Xenomics, Inc., Richmond, CA 94805, USA. Expert Opin Ther Targets. 2003 Feb;7(1):61-9.
DOI Direct Link

Xenomics (XNOM.PK) Financial information Links from Barchart

XNOM.PK Quote from from Barchart.com
XNOM.PK Chart from from Barchart.com
XNOM.PK Profile from from Barchart.com
XNOM.PK Opinion from from Barchart.com

View more Xenomics finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 281 times since April 2007, the link to the organisation's website has been followed 68 times

Recent Search Terms used to find this page: xenomics | xenomics 2008 | xenomics | Transrenal DNA testing progress and perspectives | xenomics 2008 | xenomics 2008 | xnom.pk | .

Search for more companies in New York

Search for more companies in New York



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Xenomics
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.